Combining CDK12 and BAF inhibition synergistically impairs cancer cell survival in triple-negative breast cancer line
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 66 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 66 samples: 66 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE311170_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1368744 and SRA study SRP648473. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 66 sample titles: 66 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9320488 CDK12_control_0h_1_(240403_CD_Hs_798)
- GSM9320489 BRG1_control_0h_1_(240403_CD_Hs_799)
- GSM9320490 CUTAC_control_0h_1_(240403_CD_Hs_804)
- GSM9320491 CDK12_control_0h_2_(240403_CD_Hs_805)
- GSM9320492 BRG1_control_0h_2_(240403_CD_Hs_806)
- GSM9320493 CUTAC_control_0h_2_(240403_CD_Hs_811)
- GSM9320494 CDK12_THZ531_2h_1_(240403_CD_Hs_812)
- GSM9320495 BRG1_THZ531_2h_1_(240403_CD_Hs_813)
- GSM9320496 CUTAC_THZ531_2h_1_(240403_CD_Hs_818)
- GSM9320497 CDK12_THZ531_2h_2_(240403_CD_Hs_819)
- GSM9320498 BRG1_THZ531_2h_2_(240403_CD_Hs_820)
- GSM9320499 CUTAC_THZ531_2h_2_(240403_CD_Hs_825)
- GSM9320500 CDK12_THZ531_4h_1_(240403_CD_Hs_826)
- GSM9320501 BRG1_THZ531_4h_1_(240403_CD_Hs_827)
- GSM9320502 CUTAC_THZ531_4h_1_(240403_CD_Hs_832)
- GSM9320503 CDK12_THZ531_4h_2_(240403_CD_Hs_833)
- GSM9320504 BRG1_THZ531_4h_2_(240403_CD_Hs_834)
- GSM9320505 CUTAC_THZ531_4h_2_(240403_CD_Hs_839)
- GSM9320506 CDK12_THZ531_8h_1_(240403_CD_Hs_840)
- GSM9320507 BRG1_THZ531_8h_1_(240403_CD_Hs_841)
- GSM9320508 CUTAC_THZ531_8h_1_(240403_CD_Hs_846)
- GSM9320509 CDK12_THZ531_8h_2_(240403_CD_Hs_847)
- GSM9320510 BRG1_THZ531_8h_2_(240403_CD_Hs_848)
- GSM9320511 CUTAC_THZ531_8h_2_(240403_CD_Hs_853)
- GSM9320512 CDK12_FHT1015_2h_1_(240403_CD_Hs_896)
- GSM9320513 BRG1_FHT1015_2h_1_(240403_CD_Hs_897)
- GSM9320514 CUTAC_FHT1015_2h_1_(240403_CD_Hs_902)
- GSM9320515 CDK12_FHT1015_2h_2_(240403_CD_Hs_903)
- GSM9320516 BRG1_FHT1015_2h_2_(240403_CD_Hs_904)
- GSM9320517 CUTAC_FHT1015_2h_2_(240403_CD_Hs_909)
- GSM9320518 CDK12_FHT1015_4h_1_(240403_CD_Hs_910)
- GSM9320519 BRG1_FHT1015_4h_1_(240403_CD_Hs_911)
- GSM9320520 CUTAC_FHT1015_4h_1_(240403_CD_Hs_916)
- GSM9320521 CDK12_FHT1015_4h_2_(240403_CD_Hs_917)
- GSM9320522 BRG1_FHT1015_4h_2_(240403_CD_Hs_918)
- GSM9320523 CUTAC_FHT1015_4h_2_(240403_CD_Hs_923)
- GSM9320524 CDK12_FHT1015_8h_1_(240403_CD_Hs_924)
- GSM9320525 BRG1_FHT1015_8h_1_(240403_CD_Hs_925)
- GSM9320526 CUTAC_FHT1015_8h_1_(240403_CD_Hs_930)
- GSM9320527 CDK12_FHT1015_8h_2_(240403_CD_Hs_931)
+ 26 more — browse all 66 samples with per-sample file links →
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing
- GSE186309 Genome-wide changes in RNAPII occupancy and phosphorylation in response to CDK12/13 inhibition in gliomas 14 samples shares cdk12, inhibition
- GSE288707 CDK12/13 inhibition in NSCLC cell lines with acquired resistance to sotorasib 24 samples shares cdk12, inhibition
- GSE186311 Genome-wide changes in RNAPII occupancy, RNAPII phosphorylation, and transcription in response to CDK12/13 inhibition in gliomas 20 samples shares cdk12, inhibition
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.